Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy

Journal of Diabetes and its Complications

Volumn 23, Issue 5, 2009, Pages 337-342

  Cvetković, Tatjana ^a,b   Mitić, Branka ^a   Lazarević, Gordana ^a   Vlahović, Predrag ^a   Antić, Slobodan ^a   Stefanović, Vladisav ^a  

^a Clinical Center   (Serbia)

^b Medical Faculty   (Serbia)

Author keywords

Diabetes mellitus; Diabetic nephropathy; Microalbuminuria; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; CREATINE; FRUCTOSAMINE; GLUCOSE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE;

ALBUMINURIA; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; URINALYSIS;

ALBUMINURIA; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FRUCTOSAMINE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; OXIDATIVE STRESS; PEPTIDES; PROTEIN CARBONYLATION; SPECTROPHOTOMETRY; STATISTICS, NONPARAMETRIC; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 69249200679     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.01.005     Document Type: Article

References (31)

1. Andreeva I.L., Koemjakin A.L., and Kiškun A.A. Modifikacija metoda opredelenia perekisej lipidov v teste s tiobarbiturovoj kislotoj. Laboratornoe Delo 11 (1988) 41-43
2. Apakkan Aksun S., Ozmen B., Ozmen D., Parildar Z., Senol B., Habif S., Mutaf I., Turgan N., and Bayindir O. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria. Relation to glomerular hyperfiltration. Journal of Diabetes and its Complications 17 (2003) 343-348
3. Beisswenger P.J., Drummond K.S., Nelson R.G., How S.K., Mauell M., and Szwergolder B.S. Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 54 (2005) 3274-3281
4. Bourdon E., Loreau N., and Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB Journal 13 (1999) 233-244
5. Chang J.M., Kuo M.C., Kuo H.T., Chiu Y.W., and Chen H.C. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy. Journal of Laboratory and Clinical Medicine 146 (2005) 210-215
6. Chung S., Ho E., Lam K., and Chung S. Contribution of polyol pathway to diabetes-induced oxidative stress. Journal of the American Society of Nephrology 14 (2003) S233-S236
7. Czekalski S. How to diagnose and how to interpret microalbuminuria in the diabetic patients. Nephrology Dialysis and Transplantation 11 (1996) 1509-1511
8. de Zwart L.L., Vermeulen N.P.E., Hermanns R.C.A., Commandeur J.N.M., Salemink P.J.M., and Meerman J.H.N. Urinary excretion of biomarkers for radical-induced damage in rats treated with NDMA or diquat and the effects of calcium carbimide co-administration. Chemico-Biological Interactions 117 (1999) 151-172
9. Dursun E., Dursun B., Suleymanlar G., and Ozben T. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus. Acta Diabetologica 42 (2005) 123-128
10. Dursun E., Timur M., Dursun B., Sqleymanlar G., and Ozben T. Protein oxidation in type 2 diabetic patients on hemodialysis. Journal of Diabetes and its Complications 19 (2005) 142-146
11. Elhadd T.A., Khan F., Kirk G., McLaren M., Newton R.W., Greene S.A., and Belch J.J. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes. Diabetes Care 21 (1998) 1990-1996
12. Ellman L.G. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82 (1959) 70-77
13. Evans L.J., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocrine Reviews 23 (2002) 599-622
14. Forbes J.M., Cooper M.E., Oldfield M.D., and Thomas M.C. Role of advanced glycation end products in diabetic nephropathy. Journal of American Society of Nephrology 14 (2003) s254-s258
15. Forbes J.M., Cooper M.E., Thallas V., Burns W.C., Thomas C.M., Brammar C.G., Lee F., Grant S.L., Burrell L.A., Jerums G., and Osicka T. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 5 (2002) 3274-3282
16. Giugliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19 (1996) 257-267
17. Hermanns R.C.A., Zwart L.L., Salemink P.J.M., Commandeur J.N.M., Vermeulen N.P.E., and Meerman J.H.N. Increased urinary excretion of biomarkers for oxidative kidney damage by ferric nitrilotriacetate. Toxicology Science 43 (1998) 241-249
18. Hong Y.C., and Chia S.K. Markers of diabetic nephropathy. Journal of Diabetes and its Complications 12 (1998) 43-60
19. Jackson P., Loughrey C.M., Lightbody J.H., McNamee P.T., and Young I.S. Effect of hemodialysis on total antioxidative capacity and serum antioxidants in patients with chronic renal failure. Clinical Chemistry 41 (1995) 1135-1138
20. Jakuš V., and Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiological Research 53 (2004) 131-142
21. Johnson N.R., Metcalf A.P., and Baker R.J. Fructosamine: A new approach to the estimation of serum glycosyl protein. An index of diabetic control. Clinica Chimica Acta 127 (1982) 87-95
22. Lehmann R., and Schleicher E.D. Molecular mechanism of diabetic nephropathy. Clinica Chimica Acta 297 (2000) 135-144
23. Levine R.L., Wiliams J.A., Stadtman E.R., and Shacter E. Carbonyl assay for determination of oxidative modified proteins. Methods in Enzymology 233 (1994) 46-57
24. Pasaoglu H., Samcak B., and Bukan N. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku Journal of Experimental Medicine 203 (2004) 211-218
25. Siciarz A., Weinberger B., Witz G., Hiatt M., and Hegyi T. Urinary thiobarbituric acid reacting substances as potential biomarkers of intrauterine hypoxia. Archives of Pediatrics and Adolescent Medicine 155 (2001) 718-722
26. Sundaram R.K., Bhaskar A., Vijayalingam S., Viswanathan M., Mohan R., and Shanmugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clinical Science (London) 90 (1996) 255-260
27. Telci A., Cakatay U., Salman S., Satman I., and Sivas A. Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Research and Clinical Practice 50 (2000) 213-223
28. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329 (1993) 977-986
29. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
30. Vasavada N., and Agarwal R. Role of oxidative stress in diabetic nephropathy. Advances in Chronic Kidney Disease 12 (2005) 146-154
31. Wittenstein B., Klein M., Finckh B., Ullrich K., and Kohlschutter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radical Biology and Medicine 33 (2002) 103-110